Found 4 articles for: "immune dysregulation"
Treatment of Seborrheic Dermatitis and Post-Inflammatory Hypopigmentation With Roflumilast Foam in Skin of Color Patients
June 2026 | Volume 25 | Issue 6 | Features | 572 | Copyright © June 2026
Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis
November 2025 | Volume 24 | Issue 11 | Features | 1144 | Copyright © November 2025
Read MorePost-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management
September 2025 | Volume 24 | Issue 9 | Case Reports | 938 | Copyright © September 2025
Background: Alopecia universalis (AU) is the most severe form of alopecia areata (AA), characterized by complete scalp and body hair loss. While post-COVID-19 hair loss is often ...
Read MoreThe Frequency of Non-Scarring Alopecia in Autoimmune Connective Tissue Diseases
March 2025 | Volume 24 | Issue 3 | Original Article | 246 | Copyright © March 2025
Background: Autoimmune connective tissue diseases (ACTDs) are relatively rare systemic diseases featured by immune dysregulation and often have prominent cutaneous manifestations...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
